Viking Therapeutics VKTX Return on equity

Return on equity at other companies

Eli LillyLLY

102.4%+15.7pp

PfizerPFE

10.6%—

AmgenAMGN

91.5%-7.7pp

Gyre Therapeutics, Inc.GYRE

-16%-18.3pp

Madrigal Pharmaceuticals, Inc.MDGL

-53.3%+47.0pp

VAN

Vivani MedicalVANI

-176.4%+175pp

FAQ

What is Viking Therapeutics's return on equity?

Viking Therapeutics (VKTX) reported return on equity of -70% in Q1 2026.

How has Viking Therapeutics's return on equity changed year-over-year?

Viking Therapeutics's return on equity decreased by 386.3% year-over-year, from -14.4% to -70%.

What is the long-term trend for Viking Therapeutics's return on equity?

Over 5 years (2020 to 2025), Viking Therapeutics's return on equity has grown at a 25.6% compound annual growth rate (CAGR), from -15.1% to -47.3%.

What does return on equity mean?

Trailing-twelve-month net income divided by average shareholders' equity (average of the start and end of the trailing-twelve-month window). Measures the profit generated on each dollar of shareholder capital.